Focal therapy in localised prostate cancer: Real-world urological perspective explored in a cross-sectional European survey

Baumgarten, 2017, Penile sparing surgery for penile cancer: a multicenter international retrospective cohort, J Urol, 199, 1233, 10.1016/j.juro.2017.10.045 1991, Treatment of early-stage breast cancer, JAMA, 265, 391, 10.1001/jama.1991.03460030097037 Cheng, 2015, Minimally invasive resection of early lung cancers, Oncology, 29, 160 Ljungberg B, Bensalah K, Bex A, et al. EAU guidelines renal cell cancer 2015. http://uroweborg/wp-content/uploads/EAU-Guidelines-Renal-Cell-Cancer-2015-v2pdf. Mottet, 2017, EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent, Eur Urol, 71, 618, 10.1016/j.eururo.2016.08.003 Ahmed, 2012, Transatlantic consensus group on active surveillance and focal therapy for prostate cancer, BJU Int, 109, 1636, 10.1111/j.1464-410X.2011.10633.x van der Poel, 2018, Focal therapy in primary localised prostate cancer: the European Association of Urology Position in 2018, Eur Urol, 74, 84, 10.1016/j.eururo.2018.01.001 NICE Guidelines - Prostate Cancer. https://wwwniceorguk/guidance/conditions-and-diseases/cancer/prostate-cancer Accessed on January 9, 2018. Marra, 2016, Changing the prostate cancer management pathway: why focal therapy is a step forward, Archivos Esp Urol, 69, 271 Giannarini, 2014, Will focal therapy remain only an attractive illusion for the primary treatment of prostate cancer?, J Clin Oncol, 32, 1299, 10.1200/JCO.2013.54.8214 Gandaglia, 2016, Excellent erectile function recovery after focal therapy: is this enough?, Eur Urol, 69, 852, 10.1016/j.eururo.2015.11.014 Yap, 2016, Eur Urol, 69, 853, 10.1016/j.eururo.2015.11.037 Valerio, 2014, Focal therapy will become a standard option for selected men with localized prostate cancer, J Clin Oncol, 32, 3680, 10.1200/JCO.2014.56.7792 Eysenbach, 2004, Improving the quality of web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES), J Med Internet Res, 6, e34, 10.2196/jmir.6.3.e34 Ahmed, 2014, Can we deliver randomized trials of focal therapy in prostate cancer?, Nat Rev Clin Oncol, 11, 482, 10.1038/nrclinonc.2014.44 van den Bos, 2014, Focal therapy in prostate cancer: international multidisciplinary consensus on trial design, Eur Urol, 65, 1078, 10.1016/j.eururo.2014.01.001 Donaldson, 2015, Focal therapy: patients, interventions, and outcomes—a report from a consensus meeting, Eur Urol, 67, 771, 10.1016/j.eururo.2014.09.018 Valerio, 2016, New and established technology in focal ablation of the prostate: a systematic review, Eur Urol, 71, 17, 10.1016/j.eururo.2016.08.044 Wilt, 2012, Radical prostatectomy versus observation for localized prostate cancer, N Engl J Med, 367, 203, 10.1056/NEJMoa1113162 Azzouzi, 2017, Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial, Lancet Oncol, 18, 181, 10.1016/S1470-2045(16)30661-1 Albisinni, 2017, Comparing high-intensity focal ultrasound hemiablation to robotic radical prostatectomy in the management of unilateral prostate cancer: a matched-pair analysis, J Endourol, 31, 14, 10.1089/end.2016.0702 Garcia-Barreras, 2018, Comparative analysis of partial gland ablation and radical prostatectomy to treat low and intermediate risk prostate cancer: oncologic and functional outcomes, J Urol, 199, 140, 10.1016/j.juro.2017.08.076 Bahn, 2012, Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years, Eur Urol, 62, 55, 10.1016/j.eururo.2012.03.006 Leslie TE, 2017, A phase III study comparing partial prostate ablation versus radical prostatectomy (PART) in intermediate risk prostate cancer—initial data from the feasibility study, Eur Urol Suppl, 16, e1316, 10.1016/S1569-9056(17)30814-X Surcel, 2015, Preferences in the management of high-risk prostate cancer among urologists in Europe: results of a web-based survey, BJU Int, 115, 571, 10.1111/bju.12796